Figure 2 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib
<p>Baseline radiographic disease burden highlighting SOLD per RECIST v1.1; the proportion of patients with ≥3 target lesions and selected lesion sites in (<b>A</b>) the overall population, (<b>B</b>) treatment-naïve patients, and (<b>C</b>) previously treate...
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , , , |
| Publicado em: |
2025
|
| Assuntos: | |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|